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KESAN TERAPI PERIODONTAL TANPA PEMBEDAHAN KE ATAS 
PARAMETER PERIODONTAL, PARAS PENANDA KERADANGAN DAN 
PENUNJUK FUNGSI GINJAL DALAM PESAKIT PENYAKIT GINJAL 
KRONIK DAN PERIODONTIK KRONIK 
ABSTRAK 
Penyakit ginjal kronik (PGK) berkait dengan penyakit periodontium kerana 
keadaan hiperinflamasi kedua-dua penyakit tersebut. Maka penyakit periodontium 
dikatakan sebagai faktor risiko bukan tradisi kepada penyakit ginjal kronik.  Terapi 
periodontium tanpa pembedahan adalah terapi piawai periodontitis. Akan tetapi, 
sedikit diketahui akibat kesan terapi ini ke atas parameter periodontium di dalam 
pesakit PGK pre-dialisis dan periodontitis pada populasi setempat. Kajian ini bertujuan 
untuk menyelidik dan perbandingan kesan terapi periodontium tanpa pembedahan 
keatas parameter periodontium klinikal dan paras kepekatan serum penanda inflamasi 
(hs-CRP, IL-6) pada pesakit PGK beserta periodontitis kronik dan periodontitis kronik 
sahaja, dan juga kesan terapi periodontium tanpa pembedahan keatas penunjuk fungsi 
ginjal di dalam pesakit PGK. Seramai 66 subjek terdiri dari 33 pesakit periodontitis 
kronik yang tiada penyakit sistemik (kumpulan 1) dan 33 pesakit PGK pre-dialisis 
peringkat III dan IV beserta periodontitis kronik (kumpulan 2) di daftar.  Parameter 
periodontium klinikal termasuk kedalaman poket periodontium, kehilangan atakmen 
klinikal, index perdarahan gingiva dan skor plak dinilai semasa temujanji pertama dan 
selepas terapi periodontium tanpa pembedahan, enam minggu kemudian (temujanji 
kedua). Serum darah juga diambil semasa temujanji untuk analisis  hs-CRP, IL-6, urea 
serum and kreatinin serum (untuk anggaran kadar filtrasi glomerulus). Pesakit PGK 
beserta periodontitis kronik (kumpulan 2) mempunyai paras parameter periodontium 




kronik periodontitis sahaja (kumpulan 1). Paras penanda inflamasi (hs-CRP and IL-6) 
juga lebih tinggi bererti (p<0.05) pada pesakit kumpulan 2 dibanding kumpulan 1. 
Penurunan bererti (p<0.05) didapati pada semua parameter periodontium klinikal dan 
penanda inflamasi pada kedua-dua kumpulan selepas terapi periodontium tanpa 
pembedahan. Akan tetapi, tiada kemajuan bererti dilihat pada kadar filtrasi glomerulus 
(urea serum and eKFG) pada pesakit kumpulan 2 selepas terapi. Kajian ini 
menunjukkan lebih keterukan periodontitis dan beban inflamasi terhadap pesakit PGK 
beserta periodontitis dibanding dengan pesakit periodontits sahaja. Kedua-dua 
kumpulan memberi respon yang baik selepas terapi dengan penurunan paras keterukan 
periodontitis dan beban inflamasi.  Sedikit kemajuan terhadap eKFG pada pesakit PGK 
selepas terapi dan sepatutnya dikaji pada masa hadapan. Oleh itu, kesihatan 






THE EFFECTS OF NON-SURGICAL PERIODONTAL THERAPY (NSPT) 
ON PERIODONTAL PARAMETERS, LEVELS OF INFLAMMATORY 
MARKERS AND KIDNEY FUNCTION INDICATORS IN CHRONIC 
KIDNEY DISEASE PATIENTS WITH CHRONIC PERIODONTITIS 
ABSTRACT 
Chronic kidney disease (CKD) is associated with periodontal disease due to 
the hyperinflammatory state in both conditions. Hence periodontal disease has 
emerged as a non-traditional risk factor for CKD. Non-surgical periodontal therapy 
(NSPT) is a standard treatment for periodontitis. However, limited is known about the 
effect of NSPT on periodontal parameters in pre-dialysis CKD patients with chronic 
periodontitis (CP) in our local population. This study was aimed to investigate and 
compare the effects of non-surgical periodontal therapy (NSPT) on clinical periodontal 
parameters and the levels of inflammatory markers (hs-CRP, IL-6) in CKD patients 
with CP and CP only patients. Moreover, the aim was to determine the effects of NSPT 
on kidney function indicators in CKD and CP patients. A total of 66 patients which 
consisted of 33 chronic periodontitis patient with no medical illness (Group 1) and 33 
pre-dialysis CKD stage III and IV patients with chronic periodontitis (Group 2) were 
enrolled. Clinical periodontal parameters including periodontal pocket depth (PPD), 
clinical attachment loss (CAL), gingival bleeding index (GBI) and plaque score (PS) 
were evaluated during the first visit and six weeks following NSPT (second visit). 
Blood samples were also obtained during both visits for the analysis of hs-CRP, IL-6, 
serum urea and serum creatinine (for estimation of GFR).CKD patients with chronic 
periodontitis (group 2) had shown significantly higher (p<0.05) levels of clinical 
periodontal parameters at baseline as compared to the patients with chronic 




also found significantly higher (p<0.05) in group 2 as compared to group 1 patients. 
Significant reduction (p<0.05) was recorded in all the clinical periodontal parameters 
and inflammatory markers in both groups following NSPT. However, the mean 
difference of 0.27 for serum urea levels and 0.21 for eGFR showed mild improvement 
of kidney function in group 2 patients following NSPT. The clinical periodontal 
parameters and levels of inflammatory markers improved in both the groups following 
NSPT. Although kidney function indicators showed no significant difference 
following NSPT, there was a slight improvement. Thus NSPT may play a role be 
helpful in halting the progression of CKD  Therefore, the periodontal health of CKD 




CHAPTER 1  
INTRODUCTION 
1.1  Background of the study 
The periodontium is a specialized tissue that acts as a supporting structure for 
functional teeth and occlusal interactions. It mainly consists of four tissues namely the 
gingiva, periodontal ligament (PDL), root cementum and alveolar bone. These 
components of periodontium play a pivotal role in the support of teeth in their alveolar 
bone (Palumbo, 2011). Destruction of the periodontium is associated with many 
factors including trauma, aging, infections, orthodontic tooth movement, systemic 
disorders, and genetic diseases. However, the role of periodontal disease in this 
destruction seems imperative. Periodontitis is a chronic inflammatory disease that 
compromises the stability of periodontium (Hajishengallis, 2015a). In periodontal 
disease, chronic inflammation is caused by the bacteria present on the tooth surface. A 
gingival crevice is produced with the downward growth of epithelium from oral 
mucosa due to the destruction of cells on both the surface of the tooth root and the 
cementum covering the root surface (Arzate et al., 2015). Among many contributing 
factors to the pathogenesis of periodontal disease, the growth and maturation of plaque 
biofilm by bacterial colonization is considered as a primary etiological factor (Kinane 
et al., 2017). The appalling consequences of this periodontal disease include 
edentulism (tooth loss) and contribution to systemic inflammation. The loss of teeth 
may cause severe damage to both the masticatory function and aesthetics leading to a 
decrease in the quality of life.  Periodontal disease can also act as a risk factor for many 




Chronic Kidney Disease (CKD) is a generic term used for the progressive loss 
of kidney functions. Under normal circumstances, the kidneys are responsible for 
several functions in the body including adjustment of fluid volume and the acid-base 
balance of plasma; emission of nitrogenous waste from the body; synthesis of 
erythropoietin, 1,25-dihydroxycholecalciferol and renin; and metabolism of different 
drugs (Gibson, 2007). The functions of kidneys are assessed on the basis of glomerular 
filtration rate (GFR) (total amount of fluid filtered through all of the functioning 
nephrons per unit of time). The current international guidelines define CKD as a 
decrease in GFR as of less than 60 mL/min per 1·73 m2 or presence of kidney damage 
markers or both for at least three months duration irrespective of the underlying cause. 
Based on the decrease of GFR, CKD has been categorized into five stages with stage 
5 being known as End-Stage Renal Disease (ESRD) (GFR <15 mL/min/l .73m2) 
characterized by bilateral, continuing deterioration of the nephrons (functional units of 
kidney) ("K/DOQI clinical practice guidelines," 2002). The long-term sustainability 
of life becomes very difficult once a person reaches the stage 5 of CKD as the kidneys 
lose the ability to carry out their essential functions leading to imbalanced homeostasis 
resulting in uremia (urea in blood), retention of harmful products like creatinine (by-
product of muscle metabolism) and loss of metabolic and endocrine functions of the 
body (Levin et al., 2013). In all high-income and middle-income countries, the leading 
causes of CKD are diabetes and hypertension. Treatment options for the patients of 
ESRD include kidney replacement therapy (dialysis or kidney transplantation), or 
conservative treatment (also called palliation or non-dialytic care) (Webster et al., 
2017). 
Inflammation is the tissue's biological reaction to harmful stimuli like 




inflammation and its markers are key factors that make vital contributions to the 
disastrous outcomes of CKD (Akchurin and Kaskel, 2015). The evidence from the 
previous research supports the fact of an increase in serum inflammatory cytokines 
with a decrease in the renal functions of the kidneys (Kir et al., 2012). Other theories 
state that increased levels of advanced glycation end products might serve as 
contributing factors to vascular inflammation due to reduced renal clearance (Martins 
et al., 2016). Many studies have also proposed the role of dental infections, such as 
periodontal disease, in the increased inflammatory burden of CKD patients 
(Ariyamuthu et al., 2013; Craig, 2008; Fisher et al., 2008b; Kshirsagar et al., 2007b). 
Atherosclerotic vascular disease and infection are important causes of morbidity and 
mortality in CKD patients and accounts for almost 38% of annual mortality with nearly 
50% of all reported deaths in CKD (dialysis stage) patients (Cengiz et al., 2007). 
Inflammation has been found to play a significant role in atherosclerotic pathogenesis 
in ESRD patients with an increase in inflammatory markers such as C-reactive protein 
(CRP) and Interleukin 6 (IL-6). These inflammatory markers stand out to be a powerful 
risk predictor for the worsening of kidney functions and cardiovascular disease 
development in CKD patients (Selim et al., 2006; Stenvinkel and Alvestrand, 2002).  
Researchers in the past two decades have been trying to establish a link 
between periodontal disease and other systemic diseases. Recent advances in both the 
fields of medical and dental have suggested a strong relationship of periodontal disease 
with other systemic disease such as diabetes (Preshaw et al., 2012), pneumonia 
(Iwasaki et al., 2018), cardiovascular disease (Chistiakov et al., 2016; Tonetti and Van 
Dyke, 2013), adverse pregnancy outcomes (Vettore et al., 2006) and CKD 
(Chambrone et al., 2013; Wehmeyer et al., 2013). The relationship of periodontitis has 




The concept of periodontitis is based on the circulation of mediators such as CRP, IL-
6 and tumor necrosis factor‐α (TNF‐α). This type of response is ignited either by local 
bacterial infection causing significant inflammatory damage to the periodontal tissue 
or by the systemic spread of bacteria or their toxins and products during the vicious 
cycle of periodontal disease (Kumar et al., 2013). The proposed concept is that 
periodontitis, being an inflammatory disease, markedly increases the already present 
systemic inflammatory burden of these diseases thus proving itself as a risk factor for 
many systemic diseases including CKD (Choudhury, 2010; Fisher and Taylor, 2009). 
The increase in the levels of CRP and IL-6 in periodontal disease and their marked 
decrease after non-surgical periodontal therapy (NSPT) also supports the above 
concept (Paraskevas et al., 2008b; Zhang et al., 2016). Based on the above evidence, 
the fundamental hypothesis of this research project was developed as below 
CKD subjects compared to non-CKD subjects have a higher prevalence of 
periodontal infections that worsen the systemic inflammatory status leading to the poor 
renal outcome. Improving oral health status by non-surgical periodontal therapy 
(NSPT) and better oral health care can improve the quality of life of these patients by 
improving their inflammatory status and renal function. 
1.2 Justification of the study/ Study Rationale 
CKD is ranked fourteenth in the list of leading causes of death worldwide and 
was reported to be the cause of  864 226 deaths (or 1·5% of deaths worldwide) in 2012 
according to WHO global health estimate (Webster et al., 2017). The role of chronic 
periodontitis in the etiopathogenesis of CKD and other systemic diseases seems pivotal 
(Chen et al., 2011; Fisher et al., 2008b; Ricardo et al., 2015). The current study mainly 




and the impact of NSPT in improving clinical periodontal status as well as systemic 
inflammatory profile in these subjects. Also, the dearth of scientific evidence regarding 
the effects of NSPT on systemic inflammatory status of CKD patients also justifies the 
need for this clinical trial.  There are multiple benefits of this study to the participating 
subjects and the community.  
This study will help us to better understand the two-way relationship between 
chronic periodontitis and CKD. Moreover, the assessment of inflammatory markers 
(hs-CRP, IL-6), serum urea and eGFR may serve as important biomarkers in the 
diagnosis of CKD and also for the prognostic follow-up. Also, targeted therapy aimed 
at improving these inflammatory markers may serve as a useful adjunct for the 
treatment of CKD. It will also help us to understand the effects of non-surgical 
periodontal therapy (scaling and root planning) in the patients having both the diseases 
which will be very useful to improve the CKD condition in its reversible stages (Ш 
and Ⅳ) and stop its progression to irreversible stage Ⅴ, which marks an irreversible 
threatening effect on the morbidity and mortality of CKD subjects and requires dialysis 
thus increasing the cost and putting extra burden on these patients. This study will also 
serve as a link between medical and dental professionals thus increasing their 






1.3.1 General:  
To investigate the changes in periodontal parameters, inflammatory markers and 
kidney function indicators of CKD with chronic periodontitis patients and chronic 
periodontitis only patients following non-surgical periodontal therapy (NSPT). 
1.3.2 Specific:  
1. To asses and compare the mean changes in the periodontal parameters (periodontal 
pocket depth (PPD), clinical attachment loss (CAL), gingival bleeding index (GBI) 
and plaque score (PS)) before and after a non-surgical periodontal therapy (NSPT) 
in CKD with chronic periodontitis patients and chronic periodontitis only patients. 
2. To asses and compare the mean changes in the hs-CRP and IL-6 before and after a 
non-surgical periodontal therapy (NSPT) in CKD with chronic periodontitis 
patients and chronic periodontitis only patients. 
3. To asses and compare the mean changes in the serum urea before and after a non-
surgical periodontal therapy (NSPT) therapy in CKD patients with chronic 
periodontitis. 
4. To asses and compare the mean changes in the eGFR before and after a non-surgical 
periodontal therapy (NSPT) in CKD patients with chronic periodontitis. 
5. To determine the effect size of the non-surgical periodontal therapy (NSPT) on the 
change in periodontal parameters and inflammatory markers (hs-CRP, IL-6) in 




6. To determine the effect size of the non-surgical periodontal therapy (NSPT) on the 
change in kidney function indicators (serum urea, eGFR) in CKD with chronic 
periodontitis patients. 
1.4 Research Question(s) 
1 What is the difference in the measurements of clinical periodontal parameters, 
levels of inflammatory markers (hs-CRP, IL-6) and in CKD with chronic 
periodontitis patients and chronic periodontitis only patients at the baseline? 
2 What is the difference of change in the clinical periodontal parameters before and 
after non-surgical periodontal therapy (NSPT)  in CKD with chronic periodontitis 
patients and chronic periodontitis only patients? 
3 What is the difference of change in the levels of inflammatory markers (hs-CRP 
and IL-6), before and after non-surgical periodontal therapy (NSPT) in CKD with 
chronic periodontitis patients and chronic periodontitis only patients? 
4 Does non-surgical periodontal therapy (NSPT) have any effect on kidney function 




CHAPTER 2  
LITERATURE REVIEW 
2.1 Periodontitis 
The periodontium comprises of the investing and supporting tissues of the 
tooth. It has been divided into two parts: the gingiva and the attachment apparatus 
(Palumbo, 2011). The attachment apparatus of normal periodontium consists of  
 Periodontal ligaments: Connective tissues surrounding the root and attaching it to 
the alveolar bone. Their role is to provide resistance against the occlusal forces 
(shock absorption).  
 Cementum: calcified avascular mesenchymal tissue that shapes the outer covering 
of the anatomic root. 
 Alveolar Bone: Portion of the maxilla and mandible that forms and supports the 
tooth sockets (alveoli) (Palumbo, 2011). 
 
To differentiate between the healthy and diseased state of the gingiva, one must be 
aware of the normal/healthy state (figure 2.1A). With its firm and resilient consistency, 
stippled surface texture, coral pink color, and the contour according to the shape of the 
tooth, it is attached to the tooth at a certain level known as the cementoenamel junction. 














Figure 2.1: An illustration of (A) Normal periodontium and (B) diseased 





Periodontal disease is usually caused by pathogenic microbiota present in the 
biofilm or layer of dental plaque flanking the teeth on a daily basis (Pihlstrom et al., 
2005). The two most common types of periodontal disease are plaque-induced 






Figure 2.2: Classification of periodontal disease 
 
 
The mildest form of periodontal disease is called gingivitis, also known as 
plaque-induced gingivitis, which is restricted to gingival tissue only and induced due 
to bacterial plaque accumulation at the gingival margin. It may clinically present as 
swollen, red gingiva that bleeds easily on probing, without loss of periodontal structure 
(figure 2.1B). It is highly prevalent and can be promptly reversed by effective oral 
hygiene (Albandar and Rams, 2002). 
A more aggressive form of periodontal disease is called periodontitis. It can be 
explained as the inflammation that spreads deep into the tissues and causes loss of both 
supporting connective tissues and alveolar bone. The formation of soft tissue pockets 
or deep crevices between the gingiva and tooth root known as periodontal pockets are 
associated with periodontitis (figure 2.1B). The severe form of periodontitis may lead 







affects the effective mastication and also decrease the quality of life of the patient  
(Nguyen et al., 2017; Pihlstrom et al., 2005). 
 
Clinical presentation of periodontitis 
Periodontitis can be clinically diagnosed by measuring clinical parameters of 
periodontitis such as periodontal pocket depth (PPD), clinical attachment loss (CAL), 
gingival bleeding index (GBI) and plaque score (PS). 
In order to determine the presence and extent of the periodontal lesion, 
periodontal probing is one of the most useful diagnostic tools. The measurement from 
the margin of the gingiva to the base of gingival sulcus is called periodontal probing 
depth (PPD). Whereas, clinical attachment loss (CAL) is defined as the distance 
between the base of the probable periodontal pocket and a fixed point on the crown of 





















Gingival bleeding is one of the prime symptoms of inflammation in periodontal 
tissues. It is measured by gently probing the inflamed gingiva and recorded as positive 
if bleeding appears within few seconds of probing due to ulceration of pocket 





Figure 2.4: Oral cavity of the patient showing profuse spontaneous gingival bleeding 




Dental plaque is a structured, hard yellow-grayish substance that adheres 
persistently to intraoral hard surfaces and is composed of bacteria in a matrix salivary 
glycoproteins and extracellular polysaccharides. It is considered as the primary 
etiological factor in gingivitis and periodontitis development. The measurement of 
plaque score (PS) has a very important diagnostic value in periodontal disease 
(O'Leary, 1967) (figure 2.5).  
 
Figure 2.5: Presence of dental calculus (hardened dental plaque at the lingual surface 
of the lower anterior) 
 
 
Classification of periodontitis 
 
Classification of periodontitis is of fundamental importance for the prompt diagnosis 
and treatment of the disease. The most accepted and acknowledged classification of 
periodontal disease was given by Armitage back in 1999 which subclassified the 
disease into chronic periodontitis, aggressive periodontitis, periodontitis as a 




abscesses (Armitage, 1999). However 17 years later, in a World workshop, a 
consensus was made by the workgroup by reviewing, debating and agreeing on overall 
conclusions of the five position papers published by different prominent personals in 
the field of periodontology (Papapanou et al., 2018). The conclusion of this 








2.1.1 Prevalence of periodontitis 
The attempts made to determine the prevalence and severity of periodontal 
diseases were undermined due to a lack of consensus on the declaration of universal 
clinical criteria to define the presence and severity of the disease. For example, the 
unanimity on types of clinical measurements to be recorded during the examination 
(e.g. probing depth, clinical attachment level, bleeding upon probing, etc.) and the 
inclusion criteria (whether to include all teeth or to perform a partial sampling within 
an individual need to be examine) couldn’t be achieved in the previous studies related 
to this topic. The American Academy of Periodontology (AAP) addressed this problem 
by developing a set of definitions to be used for the standardization of prevalence and 
severity of periodontal disease all over the world (Craig, 2016). 
According to a report on the global economic impact of dental diseases, severe 
periodontitis is declared as the sixth most common disease globally affecting 743 
million people (10.8% of the total world population) aged between 15 and 99. The 
prevalence and incidence of periodontitis were reported to be stagnated over the past 
20 years. Hispanic Americans were reported to be more affected by periodontitis 
followed by non-Hispanic blacks and Asian-Americans (Frencken et al., 2017). 
A National Health and Nutrition Examination Survey conducted in 2009-2014 
reported that an estimated 42% of dentate US adults 30 years or older had periodontitis, 
with 7.8% having severe periodontitis. The prevalence of severe periodontitis was 
found to be mostly among adults of 65 years or older, non-Hispanic blacks, Mexican 




According to the National oral health survey done by the Ministry of Health of 
Malaysia in 2013, the prevalence of periodontitis and severe periodontitis was reported 
48.5% and 18.2 % respectively (Khan et al., 2015). These numbers are likely to 
increase persistently because of the continuous growing and aging of many 
populations. 
2.1.2 Risk Factors for Periodontitis 
A large number of studies have been done to identify the risk factors involved 
in the development and progression of periodontal disease (Genco and Borgnakke, 
2013; Van Dyke and Dave, 2005). The most prominent risk factors identified by 
different studies include male gender, smoking, increased age, the presence of 
anaerobic bacteria (like Porphyromonas gingivalis, Tannerella forsythia, and others) 
in the biofilm, diabetes mellitus, obesity, and decreased socioeconomic status (Van 
Dyke and Dave, 2005). The previous literature revealed that the development and 
progression of periodontal disease are attributed to lifestyle rather than genetics. Risk 
factors for periodontitis are placed in the following groups for ease of understanding 
(Genco and Borgnakke, 2013). 
 Oral microorganisms 
 Gender, smoking, and alcohol (lifestyle) 
 Diabetes and Cardiovascular disease 
 Obesity and metabolic syndrome 
 Osteoporosis, dietary calcium, and vitamin D 
 Stress 




2.1.2(a) Oral microorganisms 
 
It is a well-established fact that periodontal disease is mainly a bacterial 
infection involving the dental plaque or biofilm. The identification of some of the most 
prominent periodontal pathogens of subgingival microbiome has been made. These 
pathogens of complex polymicrobial communities are believed to be strongly 
associated with the etiology and pathogenesis of periodontitis and are known to be 
resistant against antimicrobial agents and host defense (Genco and Borgnakke, 2013; 
Pihlstrom et al., 2005).  
The prominent anaerobic microbes associated with the pathogenesis of 
periodontitis are Porphyromonas gingivalis, Tannerella forsythia, and the spirochete 
Treponema denticola (together known as the famous “Red complex”). Some other 
species of bacteria including Actinobacillus actinomycetemcomitans, Prevotella 
intermedia, Fusobacterium and Campylobacter species have also been reported to be 
of importance in the pathogenesis of this disease (Pihlstrom et al., 2005). 
2.1.2(b) Gender 
Being of the male sex is one of the prominent risk factor for periodontitis. This 
difference of more prevalence of periodontitis in males than in females is linked to the 
difference in the lifestyles of two genders rather than genetics (Genco and Borgnakke, 
2013). According to the data collected by NHANES in 2009–2010 male gender had a 
50% higher prevalence of periodontitis than females (33% more mild, 28% more 




2.1.2(c) Tobacco Smoking and Alcohol 
Cigarette smoking has long been linked with periodontal disease and tooth loss. 
Most of the studies showed poorer oral hygiene in smokers compared with 
nonsmokers. Cigarette smoke contains more than 4,000 toxic substances such as 
carbon monoxide, carcinogens, oxidizing radicals, and nicotine. The relation of 
smoking with periodontitis has been explained on the basis of the number of pathways 
with which tobacco smoking can compromise periodontal health (Genco and 
Borgnakke, 2013). Previous literature states that tobacco smoking can cause an 
increase in periodontal pathogens like Porphyromonas gingivalis, Treponema 
denticola, and Tannerella forsythia, leading to an increase in the risk of development 
of periodontitis (Haffajee and Socransky, 2009). Also smoking has been reported to 
reduce the gingival blood flow (Bergstrom and Bostrom, 2001), cause 
polymorphonuclear neutrophil phagocytosis (Söder et al., 1999), increase the cytokine 
production (e.g., interleukin-1) (Loos et al., 2004) and delay the periodontal healing 
thus proving to be an independent risk factor for periodontitis.  
Alcohol consumption (dose dependent) has also been reported as one of the 
risk factors for periodontal disease (Tezal et al., 2004). 
2.1.2(d) Diabetes 
Diabetes and periodontitis have been reported to be in a two-way relationship 
with inflammation being a central feature of both diseases (Lalla and Papapanou, 
2011). Up-regulation of inflammatory processes and inflammatory markers such as 
interleukin-1b and prostaglandin E2 in the periodontal tissues of diabetic patients (type 




Diabetes is strongly associated with impaired wound healing, increased 
monocyte response to dental plaque antigens and compromised neutrophil chemotactic 
responses all of which lead to increased local tissue destruction (Deshpande et al., 
2010). Hyperglycemia can lead to increased inflammation, apoptosis and oxidative 
stress resulting in enhanced periodontal destruction (Genco and Borgnakke, 2013). 
2.1.2(e) Obesity  
 
Numerous studies in the past have presented evidence of the association of 
obesity and periodontal disease. There is evidence suggesting that obesity-associated 
changes in the pro-inflammatory and immune responses may lead to increased 
susceptibility to periodontal disease (Chaffee and Weston, 2010). 
2.1.2(f) Stress 
Stress is associated with poor oral hygiene, increased secretion of 
glucocorticoids that can undermine the immune functions, significantly increase 





2.1.3 Pathogenesis of Periodontitis 
A biofilm is necessary for the initiation and progression of periodontal diseases 
(Craig, 2016). Subgingival crevice is the primary habitat of periodontitis-associated 
bacteria, where the bacteria are found in separate microenvironments such as the 
biofilm, the gingival crevicular fluid (GCF) and the epithelium lining the crevice 
(Hajishengallis and Lamont, 2012a). 
This subgingival environment contains immune and inflammatory mediators 
in the balanced equation to maintain host-microbiota homeostasis in periodontium 
(Hajishengallis, 2015a). Periodontal tissue homeostasis can be described as an ‘armed 
peace’ between the host and the periodontal microbiota present in the biofilm, with 
frequent attacks by the microorganisms which are restrained by immune defenses of 
the host. This controlled inflammatory state due to a protective host response can be 
described as stable gingivitis (Hajishengallis, 2014). 
The transition from stable inflammatory state (gingivitis) to unstable or 
uncontrolled diseased state (Periodontitis) requires a microbial community imbalance- 
transition from symbiotic microbiota such as facultative bacteria (Actinomyces and 
Streptococci) to dysbiotic microbiota mainly comprises of anaerobic genera of 
Firmicutes, Proteobacteria, Spirochetes, Bacteroidetes and Synergistetes 
(Hajishengallis, 2015b). 
This transition also requires an imbalanced host immune response, caused 
either by the dysregulations of microbiota or because of defects in host 




engage through series of complex inflammatory interactions (Hajishengallis, 2014) 
(figure 2.7).  
Previously, bacterial species like Porphyromonas gingivalis, Tannerella 
forsythia and Treponema denticola (also known as red complex), were considered as 






Figure 2.7: Polymicrobial synergy and dysbiosis in susceptible hosts causes 





However recent developments based on independent metagenomic and 
mechanistic approaches suggested polymicrobial synergy and dysbiosis in the 
pathogenesis of periodontitis (the ‘PSD model’). This model suggests that P. gingivalis 
is pathogenic because of  its ability to encourage dysbiotic microbial communities and 
may act as a keystone pathogen, but it requires the help of accessory pathogens and 
overactivation by commensal bacteria known as pathobionts to cause disruption in the 
homeostasis and promote destructive inflammatory state in the suspected individuals 
(Hajishengallis and Lamont, 2012b) (figure 2.7). 
The host immune of the body causes the initial release of neutrophils at the site 
of inflammation. neutrophils fail to control the microbial dysbiosis, which can thus 
penetrate the connective tissue and interact with additional immune cell types, such as 
dendritic cells (DCs), macrophages (Mw), and Gamma delta T (γ T) cells; a subset of 
innate-like lymphocytes. These cells are then responsible for the production of 
proinflammatory mediators (such as the bone-resorptive cytokines tumor necrosis 
factor (TNF), interleukin (IL)-1b, and IL-17) also the regulation of development of T 
helper (Th) cells, which also contribute to and exaggerate the inflammatory response 
(figure 2.8).  
IL-17, by interacting with immune and connective tissue cell types such as 
neutrophils, fibroblasts, and osteoblasts, induces the production of CXC chemokines, 
matrix metalloproteinases (MMPs) and other tissue-destructive molecules such as 
reactive oxygen species (ROS), Receptor activator of nuclear factor kappa-Β ligand 
(RANKL). RANKL causes the maturation of osteoclast precursors (OCPs) leading to 
bone resorption in periodontitis (figure 2.8) (Hajishengallis, 2014).  
